Hepatitis C Treatment Center

Hepatitis C Treatment Center Hepatitis C is a virus known to cause inflammation and subsequent injury to the liver. It is the most common blood borne infection in the United States; an estimated 3.9 million Americans are infected. Hepatitis C is the leading indication for liver transplantation and a major cause of Cirrhosis and Hepatocellular Carcinoma (Centers for Disease Control and Prevention, 2001).

According to the Centers for Disease Control and Prevention (2001), individuals with the following risk factors should be screened for Hepatitis C: a.) Blood transfusion or solid organ transplant before 1992, b.) Injection or intranasal drug use, c.) History of dialysis, d.) HIV infection, e.) Persistently abnormal alanine aminotransferase levels (ALT), f.) Born to a HCV positive mother.

Hepatitis C can often be present without symptoms. Many patients feel quite healthy until significant liver damage causes the liver to begin to fail. If you fall into any of the above risk categories or are concerned you may have been exposed to Hepatitis C, please talk to your doctor. Treatment is available in the form of medications including Peg Intron/Ribavirin www.pegintron.com and the newly released Pegasys/Copegus www.pegasys.com Dr. Sandhu and Melissa Stanczak, FNP specialize in the treatment of Hepatitis C.

For Additional Information, Please go to Chronic Viral Hepatitis or HCV Advocate